Cerebrum Therapeutics wint biotech startup pitch wedstrijd mede gesponsord door Scientist.com en iPEPS-ICM
SAN DIEGO & PARIJS–(BUSINESS WIRE)–
Bedrijf gevestigd in Frankrijk ontvangt grootste eer in startup wedstrijd voor biotech-bedrijven in vroege stadia van het versnellen van onderzoek naar ziektes in het centrale zenuwstelsel.
Scientist.com, de toonaangevende online marktplaats voor uitbesteed onderzoek in levenswetenschappen, en de Brain en Spine Institute incubator, iPEPS-ICM, de eerste innovatieversneller toegewijd aan hersenziektes in Frankrijk, kondigen aan dat Cerebrum Therapeutics een biotech pitchwedstrijd heeft gewonnen met een prijzenpakket met onder andere 6 maanden gratis huur in de nieuwste faciliteiten van iPEPS in het dertiende district van Parijs, en $ 10.000 in onderzoeksdiensten geleverd door de Scientist.com marktplaats. Tweede plek Cairn Biosciences krijgen 3 maanden gratis huur bij iPEPS en $ 6.000 in onderzoeksdiensten bij Scientist.com.
Cerebrum Therapeutics Wins Biotech Startup Pitch Competition Co-Sponsored by Scientist.com and iPEPS-ICM
SAN DIEGO & PARIS–(BUSINESS WIRE)–
France-based company takes top honors in startup competition for early stage biotechs accelerating CNS disease research
Scientist.com, the life science industry’s leading online marketplace for outsourced research, and the Brain and Spine Institute incubator, iPEPS-ICM, the first innovation accelerator dedicated to brain diseases in France, announced that Cerebrum Therapeutics won a biotech pitch competition with a prize package that includes 6 months free rent at iPEPS’ state-of-the-art facilities located in Paris’ 13th district and $10K USD in research services provided through the Scientist.com marketplace. Runner-up Cairn Biosciences will receive 3 months free rent at iPEPS and $6K USD in research services through Scientist.com.
“It is an honor to be recognized by the Brain and Spine Institute and Scientist.com for our efforts to develop novel treatments for brain diseases and injuries,” said Vincent Serra, PhD, CEO and Co-Founder of Cerebrum Therapeutics. “The prizes will go a long way toward accelerating our breakthrough approach to testing promising chemical and biological properties in the CNS field.”
Based in Paris, France, Cerebrum Therapeutics develops first-in-class small chemical molecules for the treatment of neurodegenerative diseases and brain injuries. Their first program is dedicated to development of a new drug to target the Tauopathy indication, with orphan drug designation. San Francisco, USA-based Cairn Biosciences, who finished second in the competition, develops next-generation therapeutics that overcome resistance to cancer therapy. Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies.
“This startup call is aimed at helping young biotech entrepreneurs fast track the development of their innovative projects in one of the most thriving research and innovation ecosystems in Europe,” commented Dan Kagan, PhD, COO of Scientist.com. “It’s these types of collaborative efforts that will help find cures for neurological disorders, which affect nearly a billion people globally.”
About Scientist.com
Scientist.com is the world’s leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo among others. Visit scientist.com to learn more.
Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook, Google+ and Instagram.
About the Brain and Spine Institute
Located in the heart of the Pitié-Salpêtrière University Hospital Center, the first neurology hospital in France, the Brain and Spine Institute (ICM) is a strong link between basic research and the clinical world. The Institute consists of over 700 researchers and clinicians, 12 cutting-edge technological platforms and 1000m² office space intended for incubation of startups. The objective is to produce ambitious research by combining scientific creativity and therapeutic purpose.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005116/en/
Contacts
Media Contact:
Scientist.com
Sean Preci
Director of Communications
+1 858 455-1300 ext. 401
marketing@scientist.com
or
For further information, please contact:
The Brain and Spine Institute
Axelle de Chaillé
+33 (0)1.57.27.47.02 / +33 (0)7.63.31.55.96
axelle.dechaille@icm-institute.org